S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Osmotica PharmaceuticalsBioXcel TherapeuticsNature's Sunshine ProductsAdamas PharmaceuticalsAcasti Pharma
SymbolNASDAQ:OSMTNASDAQ:BTAINASDAQ:NATRNASDAQ:ADMSNASDAQ:ACST
Price Information
Current Price$3.46$5.04$9.31$4.04$1.97
52 Week RangeBuyBuyN/AHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/AHoldBuy
Consensus Price Target$13.00$22.33N/A$18.44$6.94
% Upside from Price Target275.72% upside343.12% upsideN/A356.55% upside252.16% upside
Trade Information
Market Cap$243.75 million$82.27 million$180.26 million$111.64 million$173.80 million
BetaN/A2.960.651.61.29
Average Volume109,04767,46214,881500,870996,329
Sales & Book Value
Annual Revenue$263.70 millionN/A$364.81 million$34.05 millionN/A
Price / Sales0.68N/A0.493.30N/A
Cashflow$2.40 per shareN/A$0.46 per shareN/AN/A
Price / Cash1.44N/A20.33N/AN/A
Book Value$7.50 per share$2.49 per share$6.28 per share$3.29 per share$0.14 per share
Price / Book0.46N/A1.481.23N/A
Profitability
Net Income$-109,400,000.00$-19,270,000.00$-850,000.00$-131,000,000.00$-39,290,000.00
EPS($0.51)($1.32)N/A($4.87)($0.71)
Trailing P/E RatioN/AN/A30.03N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-97.91%N/A0.82%-241.41%N/A
Return on Equity (ROE)-32.14%-77.72%4.83%-149.97%-515.94%
Return on Assets (ROA)-15.08%-66.59%2.93%-50.94%-102.77%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.05%0.04%0.18%3.05%N/A
Current Ratio1.78%3.93%1.66%7.27%1.61%
Quick Ratio1.49%3.93%0.97%7.05%1.61%
Ownership Information
Institutional Ownership Percentage6.93%20.39%75.67%63.41%3.04%
Insider Ownership Percentage4.70%64.80%20.30%24.90%N/A
Miscellaneous
Employees46618905159N/A
Shares Outstanding51.52 million15.73 million19.30 million27.77 million85.20 million
Next Earnings Date11/14/2019 (Estimated)11/8/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
 Osmotica PharmaceuticalsBioXcel TherapeuticsNature's Sunshine ProductsAdamas PharmaceuticalsAcasti Pharma

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel